Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Using AI-driven automation, such mRNA vaccines could be produced robotically within 48 ... boosting investor confidence in Moderna and its potential role in AI-driven healthcare advancements. MRNA ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

Investing.com -- Moderna , Inc. (NASDAQ: MRNA) shares surged 14% following remarks by Oracle (NYSE: ORCL) Chairman Larry ...

The U.S. Department of Health and Human Services (HHS) has announced $590 million in funding to Moderna to expedite the ...

This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research.

The deal marks 10-year-old Moderna’s first acquisition. The company develops mRNA therapeutics and vaccines, and the move will enable it to utilise the synthetic biology and enzyme tech of 2018 ...

With only one commercial product – the COVID-19 vaccine – Moderna faces pressure to diversify its pipeline rapidly. As the company invests heavily in expanding its non-COVID mRNA vaccine ...

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.